Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · derivative · entry 8 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,460 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · derivative · entry 7 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 11,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · nonDerivative · entry 5 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · nonDerivative · entry 3 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:29 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019303 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · derivative · entry 9 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · derivative · entry 8 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,460 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · derivative · entry 7 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · nonDerivative · entry 5 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · nonDerivative · entry 3 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019301 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:28 UTC |
NACHTSHEIM JAMI KDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,127 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-017314 · doc4.xml · derivative · entry 2 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,127 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on anniversary of the date of grant. Read SEC document |
| March 04, 2022 Filed Mar 9, 2022 00:28 UTC |
NACHTSHEIM JAMI KDirector
|
Exercise / conversionCommon Stock | 5,127 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-017314 · doc4.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 02:18 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantOption (Right to Buy) · Derivative | 435,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-014447 · doc4.xml · derivative · entry 6 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,000 Underlying: Common Stock · 435,000 shares Expires 2032-02-28 F7 · price: Not applicable. F8 · derivative.exercise_date: One forth (1/4) of the shares subject to the Option shall vest on the first anniversary of the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 02:18 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantCommon Stock | 217,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014447 · doc4.xml · nonDerivative · entry 4 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,811,518 F5 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:02 UTC |
Moore CarolSVP Reg. & Quality
|
GrantOption (Right to Buy) · Derivative | 90,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-015971 · doc4.xml · derivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2032-02-28 F4 · price: Not applicable. F3 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:02 UTC |
Moore CarolSVP Reg. & Quality
|
GrantRestricted Stock Unit | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015971 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,344 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 2,068 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/22. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:54 UTC |
Jensen ChrystalChief Legal Officer
|
GrantOption (Right to Buy) · Derivative | 105,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-015940 · doc4.xml · derivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-02-28 F4 · price: Not applicable. F3 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:54 UTC |
Jensen ChrystalChief Legal Officer
|
GrantRestricted Stock Unit | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015940 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,741 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 1,203 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/22. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:49 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantOption (Right to Buy) · Derivative | 180,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-015936 · doc4.xml · derivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2032-02-28 F4 · price: Not applicable. F3 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:49 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantRestricted Stock Unit | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015936 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,248 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 1,445 and 2,164 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/21 and 02/28/22, respectively. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:44 UTC |
Green Kevin DennisChief Financial Officer
|
GrantOption (Right to Buy) · Derivative | 140,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-015928 · doc4.xml · derivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2032-02-28 F3 · price: Not applicable. F2 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:44 UTC |
Green Kevin DennisChief Financial Officer
|
GrantRestricted Stock Unit | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015928 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,999 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:40 UTC |
CORASH LAURENCE MChief Scientific Officer
|
GrantOption (Right to Buy) · Derivative | 90,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-015921 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2032-02-28 F3 · price: Not applicable. F2 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:40 UTC |
CORASH LAURENCE MChief Scientific Officer
|
GrantRestricted Stock Unit | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015921 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,072,586 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:36 UTC |
Benjamin Richard JChief Medical Officer
|
GrantOption (Right to Buy) · Derivative | 105,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-015911 · doc4.xml · derivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-02-28 F3 · price: Not applicable. F2 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:36 UTC |
Benjamin Richard JChief Medical Officer
|
GrantRestricted Stock Unit | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015911 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,535 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 02:18 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionOption (Right to Buy) · Derivative | 380,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-22-014447 · doc4.xml · derivative · entry 5 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 380,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: Not applicable. F6 · derivative.exercise_date: One eighth (1/8) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest monthly thereafter. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 02:18 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 93,000 | $5.73 | $532,648.20 |
DisclosureSEC source: 0001209191-22-014447 · doc4.xml · nonDerivative · entry 3 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,594,018 F2 · shares: Represents shares sold to cover the exercise price, the statutory tax withholding obligations and corresponding brokerage fee in connection with the exercise of the option listed in Table II prior to expiration. F4 · price: The reported price in column 4 is a weighted average price ranging from $5.665 to $5.79 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 02:18 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 215,263 | $5.69 | $1,224,394.42 |
DisclosureSEC source: 0001209191-22-014447 · doc4.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,687,018 F2 · shares: Represents shares sold to cover the exercise price, the statutory tax withholding obligations and corresponding brokerage fee in connection with the exercise of the option listed in Table II prior to expiration. F3 · price: The reported price in column 4 is a weighted average price ranging from $5.56 to $5.77 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 02:18 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 380,000 | $3.75 | $1,425,000.00 |
DisclosureSEC source: 0001209191-22-014447 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,902,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,445 and 2,164 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/21 and 02/28/22. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:24 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionOption (Right to Buy) · Derivative | 19,059 | Not disclosed Strike: $3.66 | Not disclosed |
DisclosureSEC source: 0001209191-22-001994 · doc4.xml · derivative · entry 3 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,941 Underlying: Common Stock · 19,059 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Not applicable. F3 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:24 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 19,059 | $7.00 | $133,416.81 |
DisclosureSEC source: 0001209191-22-001994 · doc4.xml · nonDerivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,276 F2 · price: This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $7.000 to $7.005. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:24 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 19,059 | $3.66 | $69,755.94 |
DisclosureSEC source: 0001209191-22-001994 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| December 28, 2021 Filed Dec 30, 2022 21:09 UTC |
SCHULZE GAILDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 25,000 | Not disclosed Strike: $3.19 | Not disclosed |
DisclosureSEC source: 0001209191-22-062981 · doc4.xml · derivative · entry 2 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date. Read SEC document |
| December 28, 2021 Filed Dec 30, 2022 21:09 UTC |
SCHULZE GAILDirector
|
Exercise / conversionCommon Stock | 25,000 | $3.19 | $79,750.00 |
DisclosureSEC source: 0001209191-22-062981 · doc4.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:29 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 5,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-21-070809 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:29 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,000 | $3.75 | $18,750.00 |
DisclosureSEC source: 0001209191-21-070809 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,027,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 40,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-21-069864 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 40,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 01:57 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 40,000 | $3.75 | $150,000.00 |
DisclosureSEC source: 0001209191-21-069864 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,022,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 01:43 UTC |
SCHULZE GAILDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 25,000 | Not disclosed Strike: $2.86 | Not disclosed |
DisclosureSEC source: 0001209191-21-063783 · doc4.xml · derivative · entry 3 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 01:43 UTC |
SCHULZE GAILDirector
|
SaleCommon Stock | 25,000 | $7.54 | $188,430.00 |
DisclosureSEC source: 0001209191-21-063783 · doc4.xml · nonDerivative · entry 2 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,116 F1 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.595 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 01:43 UTC |
SCHULZE GAILDirector
|
Exercise / conversionCommon Stock | 25,000 | $2.86 | $71,500.00 |
DisclosureSEC source: 0001209191-21-063783 · doc4.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 01:38 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionOption (Right to Buy) · Derivative | 110,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-21-063779 · doc4.xml · derivative · entry 3 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 110,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Not applicable. F4 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 01:38 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 110,000 | $7.94 | $873,191.00 |
DisclosureSEC source: 0001209191-21-063779 · doc4.xml · nonDerivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,276 F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. F2 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.81 to $8.05 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. F3 · balance_after: Includes 1,721 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/21. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 01:38 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 110,000 | $3.75 | $412,500.00 |
DisclosureSEC source: 0001209191-21-063779 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:51 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 40,000 | $7.70 | $308,000.00 |
DisclosureSEC source: 0001209191-21-063274 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,038 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.90 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. F2 · balance_after: Includes 1,185 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/21, respectively. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:47 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 95,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-21-063273 · doc4.xml · derivative · entry 4 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Not applicable. F4 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:47 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 14,126 | $7.00 | $98,882.00 |
DisclosureSEC source: 0001209191-21-063273 · doc4.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,999 F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:47 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 81,615 | $7.00 | $571,305.00 |
DisclosureSEC source: 0001209191-21-063273 · doc4.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,125 F2 · shares: This transaction was executed pursuant to a 10b5-1 plan. Includes shares required to be sold to cover commission and mandatory tax withholdings on the "sell to cover" transaction described above and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.01 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.